{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:22:39Z","timestamp":1779236559280,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,11,22]],"date-time":"2014-11-22T00:00:00Z","timestamp":1416614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,11,22]],"date-time":"2014-11-22T00:00:00Z","timestamp":1416614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Triple Negative Breast Cancers (TNBC) represent about 12% to 20% of all breast cancers (BC) and have a worse outcome compared to other BC subtypes. TNBC often show a deficiency in DNA double-strand break repair mechanisms. This is generally related to the inactivation of a repair enzymatic complex involving BRCA1 caused either by genetic mutations, epigenetic modifications or by post-transcriptional regulations.<\/jats:p>\n                        <jats:p>The identification of new molecular biomarkers that would allow the rapid identification of BC presenting a BRCA1 deficiency could be useful to select patients who could benefit from PARP inhibitors, alkylating agents or platinum-based chemotherapy.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Genomic DNA from 131 formalin-fixed paraffin-embedded (FFPE) tumors (luminal A and B, HER2+ and triple negative BC) with known <jats:italic>BRCA1<\/jats:italic> mutation status or unscreened for <jats:italic>BRCA1<\/jats:italic> mutation were analysed by array Comparative Genomic Hybridization (array CGH). One highly significant and recurrent gain in the 17q25.3 genomic region was analysed by fluorescent in situ hybridization (FISH). Expression of the genes of the 17q25.3 amplicon was studied using customized Taqman low density arrays and single Taqman assays (Applied Biosystems).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>We identified by array CGH and confirmed by FISH a gain in the 17q25.3 genomic region in 90% of the <jats:italic>BRCA1<\/jats:italic> mutated tumors. This chromosomal gain was present in only 28.6% of the <jats:italic>BRCA1<\/jats:italic> non-mutated TNBC, 26.7% of the unscreened TNBC, 13.6% of the luminal B, 19.0% of the HER2+ and 0% of the luminal A breast cancers. The 17q25.3 gain was also detected in 50% of the TNBC with <jats:italic>BRCA1<\/jats:italic> promoter methylation. Interestingly, <jats:italic>BRCA1<\/jats:italic> promoter methylation was never detected in <jats:italic>BRCA1<\/jats:italic> mutated BC. Gene expression analyses of the 17q25.3 sub-region showed a significant over-expression of 17 genes in <jats:italic>BRCA1<\/jats:italic> mutated TNBC (<jats:italic>n<\/jats:italic>\u2009=\u200915) as compared to the <jats:italic>BRCA1<\/jats:italic> non mutated TNBC (<jats:italic>n<\/jats:italic>\u2009=\u200913).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>In this study, we have identified by array CGH and confirmed by FISH a recurrent gain in 17q25.3 significantly associated to <jats:italic>BRCA1<\/jats:italic> mutated TNBC. Up-regulated genes in the 17q25.3 amplicon might represent potential therapeutic targets and warrant further investigation.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13058-014-0466-y","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T20:01:54Z","timestamp":1416600114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"S\u00e9bastien","family":"Toffoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Bar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Abdel-Sater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Delr\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Hilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Cavallin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Van Criekinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Lacroix-Triki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Campone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Laure","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Roch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pascal","family":"Machiels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Canon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,22]]},"reference":[{"key":"466_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752. 10.1038\/35021093.","journal-title":"Nature"},{"key":"466_CR2","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073\/pnas.191367098.","journal-title":"Proc Natl Acad Sci USA"},{"key":"466_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M: Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006, 98: 262-272. 10.1093\/jnci\/djj052.","journal-title":"J Natl Cancer Inst"},{"key":"466_CR4","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004, 10: 5367-5374. 10.1158\/1078-0432.CCR-04-0220.","journal-title":"Clin Cancer Res"},{"key":"466_CR5","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","volume":"14","author":"MCU Cheang","year":"2008","unstructured":"Cheang MCU, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO: Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res. 2008, 14: 1368-1376. 10.1158\/1078-0432.CCR-07-1658.","journal-title":"Clin Cancer Res"},{"key":"466_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ctrv.2009.12.002","volume":"36","author":"A Bosch","year":"2010","unstructured":"Bosch A, Eroles P, Zaragoza R, Vi\u00f1a JR, Lluch A: Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research. Cancer Treat Rev. 2010, 36: 206-215. 10.1016\/j.ctrv.2009.12.002.","journal-title":"Cancer Treat Rev"},{"key":"466_CR7","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1093\/annonc\/mdp492","volume":"20","author":"O Gluz","year":"2009","unstructured":"Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U, Harbeck N: Triple-negative breast cancer\u2013current status and future directions. Ann Oncol. 2009, 20: 1913-1927. 10.1093\/annonc\/mdp492.","journal-title":"Ann Oncol"},{"key":"466_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/jmedgenet-2011-100006","volume":"48","author":"DG Evans","year":"2011","unstructured":"Evans DG, Howell A, Ward D, Lalloo F, Jones JL, Eccles DM: Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. J Med Genet. 2011, 48: 520-522. 10.1136\/jmedgenet-2011-100006.","journal-title":"J Med Genet"},{"key":"466_CR9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/bjc.2012.31","volume":"106","author":"L Robertson","year":"2012","unstructured":"Robertson L, Hanson H, Seal S, Warren-Perry M, Hughes D, Howell I, Turnbull C, Houlston R, Shanley S, Butler S, Evans DG, Ross G, Eccles D, Tutt A, Rahman N: BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50\u00a0years. Br J Cancer. 2012, 106: 1234-1238. 10.1038\/bjc.2012.31.","journal-title":"Br J Cancer"},{"key":"466_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nrc1457","volume":"4","author":"N Turner","year":"2004","unstructured":"Turner N, Tutt A, Ashworth A: Hallmarks of \u2018BRCAness\u2019 in sporadic cancers. Nat Rev Cancer. 2004, 4: 814-819. 10.1038\/nrc1457.","journal-title":"Nat Rev Cancer"},{"key":"466_CR11","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"B Lehmann","year":"2011","unstructured":"Lehmann B, Bauer J, Chen X, Sanders M, Chakravarthy A, Shyr Y, Pietenpol J: Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011, 121: 2750-2767. 10.1172\/JCI45014.","journal-title":"J Clin Invest"},{"key":"466_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1200\/JCO.2009.22.4725","volume":"28","author":"DP Silver","year":"2010","unstructured":"Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, Fatima A, Gelman RS, Ryan PD, Tung NM, De Nicolo A, Ganesan S, Miron A, Colin C, Sgroi DC, Ellisen LW, Winer EP, Garber JE: Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol. 2010, 28: 1145-1153. 10.1200\/JCO.2009.22.4725.","journal-title":"J Clin Oncol"},{"key":"466_CR13","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/annonc\/mdq624","volume":"22","author":"MA Vollebergh","year":"2011","unstructured":"Vollebergh MA, Lips EH, Nederlof PM, Wessels LFA, Schmidt MK, van Beers EH, Cornelissen S, Holtkamp M, Froklage FE, de Vries EGE, Schrama JG, Wesseling J, van de Vijver MJ, van Tinteren H, de Bruin M, Hauptmann M, Rodenhuis S, Linn SC: An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients. Ann Oncol. 2011, 22: 1561-1570. 10.1093\/annonc\/mdq624.","journal-title":"Ann Oncol"},{"key":"466_CR14","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1158\/1078-0432.CCR-10-0939","volume":"16","author":"CK Anders","year":"2010","unstructured":"Anders CK, Winer EP, Ford JM, Dent R, Silver DP, Sledge GW, Carey LA: Poly(ADP-Ribose) polymerase inhibition: \u201ctargeted\u201d therapy for triple-negative breast cancer. Clin Cancer Res. 2010, 16: 4702-4710. 10.1158\/1078-0432.CCR-10-0939.","journal-title":"Clin Cancer Res"},{"key":"466_CR15","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/bcr2334","volume":"11","author":"OA Stefansson","year":"2009","unstructured":"Stefansson OA: Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes. Breast Cancer Res. 2009, 11: R47-10.1186\/bcr2334.","journal-title":"Breast Cancer Res"},{"key":"466_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/gcc.20833","volume":"50","author":"SA Joosse","year":"2011","unstructured":"Joosse SA, Brandwijk KI, Mulder L, Wesseling J, Hannemann J, Nederlof PM: Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors. Gene Chromosome Cancer. 2011, 50: 71-81. 10.1002\/gcc.20833.","journal-title":"Gene Chromosome Cancer"},{"key":"466_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10549-008-0117-z","volume":"116","author":"SA Joosse","year":"2009","unstructured":"Joosse SA, van Beers EH, Tielen IH, Horlings H, Peterse JL, Hoogerbrugge N, Ligtenberg MJ, Wessels LF, Axwijk P, Verhoef S, Hogervorst FB, Nederlof PM: Prediction of BRCA1-association in hereditary non-BRCA1\/2 breast carcinomas with array-CGH. Breast Cancer Res Treat. 2009, 116: 479-489. 10.1007\/s10549-008-0117-z.","journal-title":"Breast Cancer Res Treat"},{"key":"466_CR18","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1158\/0008-5472.CAN-05-0570","volume":"65","author":"G J\u00f6nsson","year":"2005","unstructured":"J\u00f6nsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, Ward MR, Greshock JD, Luts L, Olsson H, Rahman N, Stratton M, Ringn\u00e9r M, Borg \u00c5, Weber BL: Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res. 2005, 65: 7612-7621.","journal-title":"Cancer Res"},{"key":"466_CR19","doi-asserted-by":"publisher","first-page":"D986","DOI":"10.1093\/nar\/gkt958","volume":"42","author":"JR MacDonald","year":"2014","unstructured":"MacDonald JR, Ziman R, Yuen RKC, Feuk L, Scherer SW: The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res. 2014, 42: D986-D992. 10.1093\/nar\/gkt958.","journal-title":"Nucleic Acids Res"},{"key":"466_CR20","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996, 93: 9821-9826. 10.1073\/pnas.93.18.9821.","journal-title":"Proc Natl Acad Sci USA"},{"key":"466_CR21","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1200\/JCO.2010.30.1010","volume":"28","author":"J Veeck","year":"2010","unstructured":"Veeck J, Ropero S, Setien F, Gonzalez-Suarez E, Osorio A, Benitez J, Herman JG, Esteller M: BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors. J Clin Oncol. 2010, 28: e563-e564. 10.1200\/JCO.2010.30.1010. author reply e565-566","journal-title":"J Clin Oncol"},{"key":"466_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012, 490: 61-70. 10.1038\/nature11412.","journal-title":"Nature"},{"key":"466_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N: The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012, 2: 401-404. 10.1158\/2159-8290.CD-12-0095.","journal-title":"Cancer Discov"},{"key":"466_CR24","doi-asserted-by":"publisher","first-page":"D957","DOI":"10.1093\/nar\/gkr959","volume":"40","author":"JLY Koh","year":"2012","unstructured":"Koh JLY, Brown KR, Sayad A, Kasimer D, Ketela T, Moffat J: COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines. Nucleic Acids Res. 2012, 40: D957-D963. 10.1093\/nar\/gkr959.","journal-title":"Nucleic Acids Res"},{"key":"466_CR25","doi-asserted-by":"publisher","first-page":"D1021","DOI":"10.1093\/nar\/gks1170","volume":"41","author":"EE Schmidt","year":"2013","unstructured":"Schmidt EE, Pelz O, Buhlmann S, Kerr G, Horn T, Boutros M: GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update. Nucleic Acids Res. 2013, 41: D1021-D1026. 10.1093\/nar\/gks1170.","journal-title":"Nucleic Acids Res"},{"key":"466_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.molcel.2009.06.021","volume":"35","author":"RD Paulsen","year":"2009","unstructured":"Paulsen RD, Soni DV, Wollman R, Hahn AT, Yee M-C, Guan A, Hesley JA, Miller SC, Cromwell EF, Solow-Cordero DE, Meyer T, Cimprich KA: A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome Stability. Mol Cell. 2009, 35: 228-239. 10.1016\/j.molcel.2009.06.021.","journal-title":"Mol Cell"},{"key":"466_CR27","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1101\/gad.1934210","volume":"24","author":"KE Hurov","year":"2010","unstructured":"Hurov KE, Cotta-Ramusino C, Elledge SJ: A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability. Genes Dev. 2010, 24: 1939-1950. 10.1101\/gad.1934210.","journal-title":"Genes Dev"},{"key":"466_CR28","doi-asserted-by":"publisher","first-page":"e1000408","DOI":"10.1371\/journal.pbio.1000408","volume":"8","author":"M S\u0142abicki","year":"2010","unstructured":"S\u0142abicki M, Theis M, Krastev DB, Samsonov S, Mundwiller E, Junqueira M, Paszkowski-Rogacz M, Teyra J, Heninger A-K, Poser I, Prieur F, Truchetto J, Confavreux C, Marelli C, Durr A, Camdessanche JP, Brice A, Shevchenko A, Pisabarro MT, Stevanin G, Buchholz F: A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. PLoS Biol. 2010, 8: e1000408-10.1371\/journal.pbio.1000408.","journal-title":"PLoS Biol"},{"key":"466_CR29","first-page":"373","volume":"3","author":"K Takazawa","year":"2006","unstructured":"Takazawa K, Tsuchiya H, Yoshimichi U, Kanazawa Y, Ii S, Tomita K: Expression analysis for the identification of genes involved in acquired resistance to cisplatin in osteosarcoma cells. Cancer Genomics Proteomics. 2006, 3: 373-381.","journal-title":"Cancer Genomics Proteomics"},{"key":"466_CR30","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1140321","volume":"316","author":"S Matsuoka","year":"2007","unstructured":"Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007, 316: 1160-1166. 10.1126\/science.1140321.","journal-title":"Science"},{"key":"466_CR31","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/carcin\/21.9.1761","volume":"21","author":"JC Rice","year":"2000","unstructured":"Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW: Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis. 2000, 21: 1761-1765. 10.1093\/carcin\/21.9.1761.","journal-title":"Carcinogenesis"},{"key":"466_CR32","doi-asserted-by":"publisher","first-page":"10692","DOI":"10.1158\/0008-5472.CAN-05-1277","volume":"65","author":"M Wei","year":"2005","unstructured":"Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, Sveen L, Xu J, Fackenthal J, Tretiakova M, Das S, Olopade OI: BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res. 2005, 65: 10692-10699. 10.1158\/0008-5472.CAN-05-1277.","journal-title":"Cancer Res"},{"key":"466_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12032-010-9438-y","volume":"28","author":"A Ali","year":"2011","unstructured":"Ali A, Iau P, Sng J-H: Cancer-specific methylation in the BRCA1 promoter in sporadic breast tumours. Med Oncol. 2011, 28: 64-66. 10.1007\/s12032-010-9438-y.","journal-title":"Med Oncol"},{"key":"466_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00428-012-1286-z","volume":"461","author":"A Bal","year":"2012","unstructured":"Bal A, Verma S, Joshi K, Singla A, Thakur R, Arora S, Singh G: BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression. Virchows Arch. 2012, 461: 305-312. 10.1007\/s00428-012-1286-z.","journal-title":"Virchows Arch"},{"key":"466_CR35","first-page":"1222","volume":"57","author":"M Tirkkonen","year":"1997","unstructured":"Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R, Tanner M, Isola J, Barkardottir RB, Borg \u00c5, Kallioniemi O-P: Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res. 1997, 57: 1222-1227.","journal-title":"Cancer Res"},{"key":"466_CR36","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1038\/bjc.2013.144","volume":"108","author":"EH Lips","year":"2013","unstructured":"Lips EH, Mulder L, Oonk A, van der Kolk LE, Hogervorst FB, Imholz AL, Wesseling J, Rodenhuis S, Nederlof PM: Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers. Br J Cancer. 2013, 108: 2172-2177. 10.1038\/bjc.2013.144.","journal-title":"Br J Cancer"},{"key":"466_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2559.2010.03642.x","volume":"57","author":"GM Bol","year":"2010","unstructured":"Bol GM, Suijkerbuijk KP, Bart J, Vooijs M, van der Wall E, van Diest PJ: Methylation profiles of hereditary and sporadic ovarian cancer. Histopathology. 2010, 57: 363-370. 10.1111\/j.1365-2559.2010.03642.x.","journal-title":"Histopathology"},{"key":"466_CR38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","unstructured":"Cancer Genome Atlas Research N: Integrated genomic analyses of ovarian carcinoma. Nature. 2011, 474: 609-615. 10.1038\/nature10166.","journal-title":"Nature"},{"key":"466_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1749-6632.2010.05780.x","volume":"1210","author":"R Bermudo","year":"2010","unstructured":"Bermudo R, Abia D, Benitez D, Carri\u00f3 A, Vilella R, Ortiz \u00c1R, Thomson TM, Fern\u00e1ndez PL: Discovery of genomic alterations through coregulation analysis of closely linked genes: a frequent gain in 17q25.3 in prostate cancer. Ann NY Acad Sci. 2010, 1210: 17-24. 10.1111\/j.1749-6632.2010.05780.x.","journal-title":"Ann NY Acad Sci"},{"key":"466_CR40","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/labinvest.3780350","volume":"81","author":"RP Zweemer","year":"2001","unstructured":"Zweemer RP, Ryan A, Snijders AM, Hermsen MA, Meijer GA, Beller U, Menko FH, Jacobs IJ, Baak JP, Verheijen RH, Kenemans P, van Diest PJ: Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma. Lab Invest. 2001, 81: 1363-1370. 10.1038\/labinvest.3780350.","journal-title":"Lab Invest"},{"key":"466_CR41","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/humu.21135","volume":"30","author":"K Leunen","year":"2009","unstructured":"Leunen K, Gevaert O, Daemen A, Vanspauwen V, Michils G, De Moor B, Moerman P, Vergote I, Legius E: Recurrent copy number alterations in BRCA1-mutated ovarian tumors alter biological pathways. Hum Mutat. 2009, 30: 1693-1702. 10.1002\/humu.21135.","journal-title":"Hum Mutat"},{"key":"466_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10549-012-2070-0","volume":"135","author":"Y Wen","year":"2012","unstructured":"Wen Y, Ho A, Patil S, Akram M, Catalano J, Eaton A, Norton L, Benezra R, Brogi E: Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation. Breast Cancer Res Treat. 2012, 135: 93-102. 10.1007\/s10549-012-2070-0.","journal-title":"Breast Cancer Res Treat"},{"key":"466_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/path.2574","volume":"219","author":"C Marchi\u00f2","year":"2009","unstructured":"Marchi\u00f2 C, Lambros MB, Gugliotta P, Di Cantogno LV, Botta C, Pasini B, Tan DSP, Mackay A, Fenwick K, Tamber N, Bussolati G, Ashworth A, Reis-Filho JS, Sapino A: Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis. J Pathol. 2009, 219: 16-24. 10.1002\/path.2574.","journal-title":"J Pathol"},{"key":"466_CR44","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/bcr2596","volume":"12","author":"G Jonsson","year":"2010","unstructured":"Jonsson G, Staaf J, Vallon-Christersson J, Ringner M, Holm K, Hegardt C, Gunnarsson H, Fagerholm R, Strand C, Agnarsson BA, Kilpivaara O, Luts L, Heikkila P, Aittomaki K, Blomqvist C, Loman N, Malmstrom P, Olsson H, Johannsson OT, Arason A, Nevanlinna H, Barkardottir RB, Borg A: Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Res. 2010, 12: R42-10.1186\/bcr2596.","journal-title":"Breast Cancer Res"},{"key":"466_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1634\/theoncologist.2012-0397","volume":"18","author":"A Prat","year":"2013","unstructured":"Prat A, Adamo B, Cheang MCU, Anders CK, Carey LA, Perou CM: Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist. 2013, 18: 123-133. 10.1634\/theoncologist.2012-0397.","journal-title":"Oncologist"},{"key":"466_CR46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1158\/1541-7786.MCR-07-0055","volume":"5","author":"MC Abba","year":"2007","unstructured":"Abba MC, Sun H, Hawkins KA, Drake JA, Hu Y, Nunez MI, Gaddis S, Shi T, Horvath S, Sahin A, Aldaz CM: Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol Cancer Res. 2007, 5: 881-890. 10.1158\/1541-7786.MCR-07-0055.","journal-title":"Mol Cancer Res"},{"key":"466_CR47","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1158\/0008-5472.CAN-08-1360","volume":"68","author":"I Bernard-Pierrot","year":"2008","unstructured":"Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, Raynal V, Vallot C, Pierron G, Radvanyi F, Delattre O: Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res. 2008, 68: 7165-7175. 10.1158\/0008-5472.CAN-08-1360.","journal-title":"Cancer Res"},{"key":"466_CR48","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/bcr3154","volume":"14","author":"R Natrajan","year":"2012","unstructured":"Natrajan R, Mackay A, Wilkerson P, Lambros M, Wetterskog D, Arnedos M, Shiu K-K, Geyer F, Langerod A, Kreike B, Reyal F, Horlings H, van de Vijver M, Palacios J, Weigelt B, Reis-Filho J: Functional characterization of the 19q12 amplicon in grade III breast cancers. Breast Cancer Res. 2012, 14: R53-10.1186\/bcr3154.","journal-title":"Breast Cancer Res"},{"key":"466_CR49","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/gut.2007.123695","volume":"57","author":"C Brockschmidt","year":"2008","unstructured":"Brockschmidt C, Hirner H, Huber N, Eismann T, Hillenbrand A, Giamas G, Radunsky B, Ammerpohl O, Bohm B, Henne-Bruns D, Kalthoff H, Leithauser F, Trauzold A, Knippschild U: Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo. Gut. 2008, 57: 799-806. 10.1136\/gut.2007.123695.","journal-title":"Gut"},{"key":"466_CR50","doi-asserted-by":"publisher","first-page":"e29709","DOI":"10.1371\/journal.pone.0029709","volume":"7","author":"H Hirner","year":"2012","unstructured":"Hirner H, Gunes C, Bischof J, Wolff S, Grothey A, Kuhl M, Oswald F, Wegwitz F, Bosl MR, Trauzold A, Henne-Bruns D, Peifer C, Leithauser F, Deppert W, Knippschild U: Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo. PLoS One. 2012, 7: e29709-10.1371\/journal.pone.0029709.","journal-title":"PLoS One"},{"key":"466_CR51","first-page":"8939","volume":"63","author":"J Walter-Yohrling","year":"2003","unstructured":"Walter-Yohrling J, Cao X, Callahan M, Weber W, Morgenbesser S, Madden SL, Wang C, Teicher BA: Identification of genes expressed in malignant cells that promote invasion. Cancer Res. 2003, 63: 8939-8947.","journal-title":"Cancer Res"},{"key":"466_CR52","doi-asserted-by":"publisher","first-page":"7069","DOI":"10.1074\/jbc.M004129200","volume":"276","author":"L-S Chin","year":"2001","unstructured":"Chin L-S, Raynor MC, Wei X, Chen H-Q, Li L: Hrs Interacts with Sorting Nexin 1 and Regulates Degradation of Epidermal Growth Factor Receptor. J Biol Chem. 2001, 276: 7069-7078. 10.1074\/jbc.M004129200.","journal-title":"J Biol Chem"},{"key":"466_CR53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature11043","volume":"487","author":"MF Barber","year":"2012","unstructured":"Barber MF, Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, Moqtaderi Z, Tennen RI, Paredes S, Young NL, Chen K, Struhl K, Garcia BA, Gozani O, Li W, Chua KF: SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature. 2012, 487: 114-118.","journal-title":"Nature"},{"key":"466_CR54","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/bcr3192","volume":"14","author":"CR Tate","year":"2012","unstructured":"Tate CR, Rhodes LV, Segar HC, Driver JL, Pounder FN, Burow ME, Collins-Burow BM: Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat. Breast Cancer Res. 2012, 14: R79-10.1186\/bcr3192.","journal-title":"Breast Cancer Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-014-0466-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-014-0466-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-014-0466-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-014-0466-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:03:48Z","timestamp":1728921828000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-014-0466-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,22]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,12]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1186\/s13058-014-0466-y","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,22]]},"assertion":[{"value":"27 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"466"}}